MFEHX
Price
$172.42
Change
-$0.48 (-0.28%)
Updated
May 9 closing price
Net Assets
42.95B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

MFEHX vs RGAHX

Header iconMFEHX vs RGAHX Comparison
Open Charts MFEHX vs RGAHXBanner chart's image
MFS Growth R3
Price$172.42
Change-$0.48 (-0.28%)
VolumeN/A
Net Assets42.95B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
MFEHX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MFEHX vs. RGAHX commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MFEHX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. MFEHX (43B). RGAHX pays higher dividends than MFEHX: RGAHX (0.54) vs MFEHX (0.00). MFEHX was incepted earlier than RGAHX: MFEHX (20 years) vs RGAHX (9 years). MFEHX (0.84) is less costly to investors than RGAHX (0.44). MFEHX is a more actively managed with annual turnover of: 33.00 vs. RGAHX (25.00). MFEHX has a lower initial minimum investment than RGAHX: MFEHX (0) vs RGAHX (250). RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. MFEHX (-5.21). RGAHX return over 5 years is better than : 44.87 vs. MFEHX (42.54).
MFEHXRGAHXMFEHX / RGAHX
Total Expense Ratio0.830.44189%
Annual Report Gross Expense Ratio0.840.44191%
Fund Existence20 years9 years-
Gain YTD-4.903-2.478198%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets43B285B15%
Annual Yield % from dividends0.000.54-
Returns for 1 year-5.213.25-160%
Returns for 3 years32.2533.4097%
Returns for 5 years42.5444.8795%
Returns for 10 years145.02N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics